chr1-47416547-G-A
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM1PP3PP5_Very_Strong
The NM_012186.3(FOXE3):c.232G>A(p.Ala78Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000451 in 1,574,228 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. A78A) has been classified as Likely benign.
Frequency
Consequence
NM_012186.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FOXE3 | NM_012186.3 | c.232G>A | p.Ala78Thr | missense_variant | 1/1 | ENST00000335071.4 | NP_036318.1 | |
LINC01389 | NR_126355.1 | n.29-6646C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FOXE3 | ENST00000335071.4 | c.232G>A | p.Ala78Thr | missense_variant | 1/1 | 6 | NM_012186.3 | ENSP00000334472.2 |
Frequencies
GnomAD3 genomes AF: 0.0000535 AC: 8AN: 149452Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000363 AC: 8AN: 220408Hom.: 0 AF XY: 0.0000330 AC XY: 4AN XY: 121036
GnomAD4 exome AF: 0.0000442 AC: 63AN: 1424776Hom.: 0 Cov.: 33 AF XY: 0.0000508 AC XY: 36AN XY: 708840
GnomAD4 genome AF: 0.0000535 AC: 8AN: 149452Hom.: 0 Cov.: 32 AF XY: 0.0000686 AC XY: 5AN XY: 72930
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Mar 28, 2023 | The FOXE3 c.232G>A; p.Ala78Thr variant (rs377669670) is reported in both the homozygous and compound heterozygous states in individuals with FOXE3-related ocular disorders (Chesneau 2022, Plaisancie 2018, Reis 2021). This variant is also reported in ClinVar (Variation ID: 427852). It is observed in the general population with a low overall allele frequency of 0.004% (10/248542 alleles) in the Genome Aggregation Database. Computational analyses predict that this variant is deleterious (REVEL: 0.862). Based on available information, this variant is considered to be likely pathogenic for autosomal recessive anterior segment dysgenesis 2. It is uncertain whether or not this variant would cause susceptibility to familial thoracic aortic aneurysm 11. References: Chesneau B et al. First evidence of SOX2 mutations in Peters' anomaly: Lessons from molecular screening of 95 patients. Clin Genet. 2022 May;101(5-6):494-506. PMID: 35170016. Plaisancie J et al. FOXE3 mutations: genotype-phenotype correlations. Clin Genet. 2018 Apr;93(4):837-845. PMID: 29136273. Reis LM et al. Comprehensive phenotypic and functional analysis of dominant and recessive FOXE3 alleles in ocular developmental disorders. Hum Mol Genet. 2021 Aug 12;30(17):1591-1606. PMID: 34046667. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 09, 2024 | This variant is associated with the following publications: (PMID: 34046667, 30187164, 29314435, 34426522, 31589614, 35170016, 29136273) - |
Congenital primary aphakia Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Genetics Department, University Hospital of Toulouse | Jun 01, 2017 | - - |
Pathogenic, no assertion criteria provided | research | Human Developmental Genetics Laboratory, Medical College of Wisconsin | May 01, 2021 | - - |
Congenital primary aphakia;C1862839:Anterior segment dysgenesis Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 14, 2022 | This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 78 of the FOXE3 protein (p.Ala78Thr). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with autosomal recessive FOXE3-related conditions (PMID: 29136273, 34046667). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 427852). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, flagged submission | clinical testing | Ambry Genetics | Nov 09, 2021 | The c.232G>A (p.A78T) alteration is located in exon 1 (coding exon 1) of the FOXE3 gene. This alteration results from a G to A substitution at nucleotide position 232, causing the alanine (A) at amino acid position 78 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at